RISW2025
Back to all people

Shu Wang

FDA
1 appearance in the program

Sessions & presentations

PS32: Innovative Designs in Oncology: Adaptive Enrichment, AI/ML-Driven Borrowing, and Regulatory Perspectives
Presentation: Regulatory Considerations for Innovative Designs in Oncology
Parallel · Fri, Sep 26 , 8:30 AM
Presenting Author
↑